·8 min read
Novo Nordisk Falls 7.65% on Its Own Investor Day: 2030 Targets, the 2032 Patent Cliff and a DKK 150 Billion Promise
At its 21 Sep 2026 Capital Markets Day Novo guided growth in line with 14 pharma peers to 2030 and DKK 150bn pipeline sales by 2035. Shares fell 7.65%.